A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

A. W. Tolcher, D. I. Quinn, A. Ferrari, F. Ahmann, G. Giaccone, T. Drake, A. Keating, J. S. De Bono

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences